A recent study of Lynch syndrome patients, using multigene panel observed that out of the 528 patients with MMR mutations, 11.9% had breast cancer and 27.3% had colorectal cancer, with MSH6 and PMS2 mutations more frequent than MLH1 and MSH2 mutations [58]. The gene discussed is MSH2; the disease is Lynch syndrome.